Resonant Capital Advisors, LLC Abbott Laboratories Transaction History

Resonant Capital Advisors, LLC

$1.22 Billion
Q2 2024

A detailed history of Resonant Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 13,116 shares of ABT stock, worth $1.48 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

13,116

Previous 12,830 2.23%

Holding current value

$1.48 Million

Previous $1.46 Million 6.58%

% of portfolio

0.11%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $28,808 - $32,157	286 Added 2.23%	13,116 $1.36 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $131,752 - $145,514	1,203 Added 10.35%	12,830 $1.46 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $25,613 - $31,353	284 Added 2.5%	11,627 $1.28 Million
Q3 2023 Oct 31, 2023	SELL	$95.53 - $114.62 $37,447 - $44,931	-392 Reduced 3.34%	11,343 $1.1 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $4,635 - $5,165	46 Added 0.39%	11,735 $1.28 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $82,137 - $96,680	-848 Reduced 6.76%	11,689 $1.18 Million
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $5,798 - $6,802	-61 Reduced 0.48%	12,537 $0
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $34,253 - $39,658	354 Added 2.89%	12,598 $1.22 Million
Q2 2022 Jul 12, 2022	BUY	$102.07 - $123.37 $72,980 - $88,209	715 Added 6.2%	12,244 $1.33 Million
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $10,831 - $13,208	-95 Reduced 0.82%	11,529 $1.37 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $62,848 - $76,954	544 Added 4.91%	11,624 $1.64 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $27,298 - $30,200	234 Added 2.16%	11,080 $1.31 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $13,646 - $16,064	129 Added 1.2%	10,846 $1.26 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $143,342 - $168,878	1,317 Added 14.01%	10,717 $1.28 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $31,500 - $34,326	-300 Reduced 3.09%	9,400 $1.03 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $24,192 - $29,380	-264 Reduced 2.65%	9,700 $1.06 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $4,517 - $5,782	-59 Reduced 0.59%	9,964 $911,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $439 - $643	-7 Reduced 0.07%	10,023 $791,000
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $787,455 - $876,622	10,030 New	10,030 $871,000

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Account

Resonant Capital Advisors, LLC Abbott Laboratories Transaction History